rs3094188
|
POU5F1;PSORS1C3
|
Crohn Disease
|
C |
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.
|
23266558 |
2013 |
rs3094188
|
POU5F1;PSORS1C3
|
Crohn Disease
|
C |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.
|
23266558 |
2013 |
rs3131018
|
POU5F1;PSORS1C3
|
HIV-1, RESISTANCE TO
|
C |
0.800 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
AIDS, PROGRESSION TO
|
C |
0.800 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
C |
0.800 |
GeneticVariation |
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
C |
0.800 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
C |
0.800 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
HIV-1, RESISTANCE TO
|
C |
0.800 |
GeneticVariation |
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
AIDS, PROGRESSION TO
|
C |
0.800 |
GeneticVariation |
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs3131018
|
POU5F1;PSORS1C3
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
C |
0.800 |
GeneticVariation |
GWASCAT |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs1265181
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
Psoriasis
|
|
0.710 |
GeneticVariation |
GWASCAT |
Genome-wide association study of psoriasis in an Egyptian population.
|
30921485 |
2019 |
rs1265181
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
Psoriasis
|
|
0.710 |
GeneticVariation |
BEFREE |
Extremely high significance of association was detected between rs1265181 and psoriasis (p combined < 10E--300, OR = 16.52, 95% CI: 15.28-18.44).
|
21208785 |
2011 |
rs1265181
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
Psoriasis
|
|
0.710 |
GeneticVariation |
GWASCAT |
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.
|
19169255 |
2009 |
rs116805908
|
POU5F1;PSORS1C3
|
Arthritis, Psoriatic
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
|
30552173 |
2019 |
rs116834467
|
POU5F1;PSORS1C3
|
Hemoglobin measurement
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs887464
|
POU5F1;PSORS1C3
|
Myasthenia Gravis
|
|
0.700 |
GeneticVariation |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
rs887466
|
POU5F1;PSORS1C3
|
Corpuscular Hemoglobin Concentration Mean
|
|
0.700 |
GeneticVariation |
GWASDB |
Seventy-five genetic loci influencing the human red blood cell.
|
23222517 |
2012 |
rs3094188
|
POU5F1;PSORS1C3
|
Stevens-Johnson Syndrome
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.
|
21801394 |
2011 |
rs3094188
|
POU5F1;PSORS1C3
|
Toxic Epidermal Necrolysis
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.
|
21801394 |
2011 |
rs1128175
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs1128175
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
HIV-1, RESISTANCE TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs1128175
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
AIDS, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs1128175
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
|
0.700 |
GeneticVariation |
GWASDB |
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
|
21051598 |
2010 |
rs1265181
|
Entrez Id: |
100130889 |
Gene Symbol: |
PSORS1C3 |
PSORS1C3
|
Vitiligo
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
|
20526339 |
2010 |
rs3130457
|
POU5F1;PSORS1C3
|
Vitiligo
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
|
20526339 |
2010 |